# TiGenix NV: Form D filings

TiGenix NV, a biotechnology company in Leuven, Belgium, filed 2 Form D notices with the SEC between 2013 and 2018. The latest, on January 9, 2018, reports $25,902 sold of a $195,412 offering to 2 investors.

Find out what TiGenix NV does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TiGenix%20NV%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TiGenix%20NV&page=%2Fdata%2Fform-d%2Fcompany%2Ftigenix-nv-1581987)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TiGenix%20NV%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TiGenix%20NV&page=%2Fdata%2Fform-d%2Fcompany%2Ftigenix-nv-1581987)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: ROMEINSE STRAAT 12 BOX 2, 3001, Leuven, Belgium, 3001
- Phone: (321) 639-7937
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Belgium
- Revenue range: $25,000,001 - $100,000,000
- Exemptions claimed: Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK): 1581987

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 9, 2018 | New notice | $195,412 | $25,902 | $169,510 | 2 | Nov 16, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1581987/000095010318000267/0000950103-18-000267-index.htm) |
| Jul 24, 2013 | New notice | $8,540,220 | $8,540,220 | $0 | 25 | Jul 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1581987/000114420413040885/0001144204-13-040885-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Claudia D'Augusta | Executive Officer |  |
| June Almenoff | Director |  |
| Russell Greig | Director |  |
| Eduardo Bravo Fernandez de Araoz | Executive Officer, Director |  |
| Jean Stephenne | Director |  |
| Marie Paule Richard | Executive Officer |  |
| Willy Duron | Director |  |
| Wilfried Dalemans | Executive Officer |  |

[Every Form D from the week of Jan 8, 2018](https://specstream.ai/data/form-d/week/2018-01-08) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what TiGenix NV reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).